Sinovac Biotech Ltd (NASDAQ:SVA)

5.10
Delayed Data
As of Apr 24
 0.00 / 0.00%
Today’s Change
4.51
Today|||52-Week Range
6.53
-2.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues22.9M13.5M12.1M17.1M
 
 
 
 
 
Cost of Goods Sold7.0M580.0K1.1M4.2M
 
 
 
 
 
Depreciation And Amortization1.3M2.7M2.0M802.0K
 
 
 
 
 
 
Operating ExpensesGross Income14.7M10.3M9.1M12.2M
 
 
 
 
 
General Expenses10.9M9.7M12.0M11.3M
 
 
 
 
 
Research And Development2.5M1.7M3.3M2.5M
 
 
 
 
 
Total Operating Expenses19.1M12.9M15.0M16.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.8M612.0K-2.9M895.0K
 
 
 
 
 
Interest Expense On Debt862.7K750.0K832.0K905.0K
 
 
 
 
 
Other Expenses2.1M146.0K42.0K-39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.7M788.0K-2.9M526.0K
 
 
 
 
 
Income Taxes-2.3M-347.0K-76.0K-419.0K
 
 
 
 
 
Minority Interest-2.1M-4.0K-774.0K-18.0K
 
 
 
 
 
Net Income5.8M437.0K-2.2M89.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.6M55.6M55.7M55.7M
 
 
 
 
 
Shares To Calculate EPS Diluted55.6M56.1M55.7M56.1M
 
 
 
 
 
 
Earnings Per ShareEPS--$0.00-$0.04$0.00
 
 
EPS Diluted$0.10$0.01-$0.04$0.00
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account